Kits EyecareFRA:0P3 +4.85%77 Net Current Asset Value is €0.34 as of Mar. 2026, which is 100% below its 10-year median of 55.40. GuruFocus rates FRA:0P3 with a GF Score™ of 77/100 and a GF Value™ of €8.18 (Fairly Valued). The stock has 1 warning sign investors should review. Among 557 Retail - Cyclical companies, Kits Eyecare ranks worse than 92.64% on this metric.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
Kits Eyecare's net current asset value per share for the quarter that ended in Mar. 2026 was €0.34.
The historical rank and industry rank for Kits Eyecare's Net Current Asset Value or its related term are showing as below:
FRA:0P3'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 14.22 Med: 55.4 Max: 86.14
Current: 27.03
During the past 8 years, the highest Price-to-Net-Current-Asset-Value Ratio of Kits Eyecare was 86.14. The lowest was 14.22. And the median was 55.40.
FRA:0P3's Price-to-Net-Current-Asset-Value is ranked worse than 92.64% of 557
companies
in the Retail - Cyclical industry
Industry Median: 3.04
vs FRA:0P3: 27.03
Kits Eyecare (FRA:0P3) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
Kits Eyecare Net Current Asset Value Related Terms
Kits Eyecare Net Current Asset Value Historical Data
* Premium members only.
The historical data trend for Kits Eyecare's Net Current Asset Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:0P3 vs CASY, WSM, DKS: Net Current Asset Value Comparison
For the Specialty Retail subindustry, Kits Eyecare's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kits Eyecare Price-to-Net-Current-Asset-Value vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Kits Eyecare's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where Kits Eyecare's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of €0.34 mean?
Kits Eyecare (FRA:0P3) has a Net Current Asset Value of €0.34 as of Mar. 2026. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Kits Eyecare and its competitors. This is 99% below median its historical median of 55.40. Over the past decade, Kits Eyecare's Net Current Asset Value has ranged from 14.22 to 86.14. According to the industry distribution chart, Kits Eyecare ranks #516 out of 557 companies in the Retail - Cyclical industry, placing it in the top 92.6%.
Is Kits Eyecare's Net Current Asset Value too high?
Kits Eyecare's current Net Current Asset Value of €0.34 is 99% below median its 10-year median of 55.40. Over the past 10 years, this metric has ranged from a low of 14.22 to a high of 86.14. Based on the distribution chart, Kits Eyecare ranks #516 out of 557 companies in the Retail - Cyclical industry, which is in the bottom quartile relative to peers. Overall, Kits Eyecare has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Kits Eyecare's Net Current Asset Value compare to CASY and WSM?
According to the Retail - Cyclical industry distribution chart, Kits Eyecare ranks #516 out of 557 companies for Net Current Asset Value. This places Kits Eyecare in the lower half of its industry. The industry median Net Current Asset Value is 3.04. Historically, Kits Eyecare's own Net Current Asset Value has ranged from 14.22 to 86.14 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Retail - Cyclical company?
The median Net Current Asset Value among Retail - Cyclical companies is 3.04, based on 557 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Kits Eyecare and its competitors. For the Retail - Cyclical industry, the median Net Current Asset Value is 3.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kits Eyecare's current Net Current Asset Value is €0.34, which is 99% below median its own 10-year median of 55.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kits Eyecare stock overvalued right now?
Based on GuruFocus' analysis, Kits Eyecare (FRA:0P3) is currently considered Fairly Valued. The stock's GF Value™ is €8.18, compared to a current price of €8.65 — trading 5.7% above its estimated fair value. The current Net Current Asset Value is €0.34, which is 99% below median its 10-year median of 55.40. Kits Eyecare's overall GF Score™ is 77/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Kits Eyecare (FRA:0P3), the current Net Current Asset Value is €0.34 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kits Eyecare (FRA:0P3) Overvalued in 2026?
Based on GuruFocus' analysis, Kits Eyecare stock appears to be overvalued.
The current stock price of €8.65 is trading 5.7% above its estimated GF Value™ of €8.18.
GuruFocus considers Kits Eyecare to be Fairly Valued.
Key valuation signals for FRA:0P3:
Net Current Asset Value: €0.34 (99% below median its 10-year median of 55.40)
GF Value™: €8.18 vs. price of €8.65 (5.7% above fair value)
No single metric tells the full story. See the FRA:0P3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kits Eyecare Ltd is a vertically integrated, digitally native eyecare platform that offers its customers access to a vast selection of the highest quality contact lenses and eyeglasses, including its exclusive KITS-designed products, and a suite of online vision tools. It operates a network of optical e-commerce websites, including KITS.com, KITS.ca, OptiContacts.com, and ContactsExpress.ca. The company's contact lens partners include Alcon, Bausch & Lomb, CooperVision, and Johnson & Johnson, and its glasses partners include Gucci, Oakley, Prive Revaux, Ray-Ban and Tom Ford. Its geographic locations are the United States; and Canada and Other which generates the majority of its revenue from the United States.
77GF Score
Get the complete analysis for FRA:0P3
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:0P3 has been successfully added to your 
